Literature DB >> 12492453

Lipopolysaccharide represses cholesterol 7-alpha hydroxylase and induces binding activity to the bile acid response element II.

N Dikopoulos1, H Weidenbach, G Adler, R M Schmid.   

Abstract

BACKGROUND: Inflammatory states such as hepatitis and sepsis are frequently associated with alterations of bile acid synthesis. These conditions are mediated by bacterial wall products like lipopolysaccharide (LPS). Cholesterol 7-alpha hydroxylase is the rate-limiting enzyme of bile acid synthesis. Hydrophobic bile acids repress cholesterol 7-alpha hydroxylase transcription via binding to the farnesoid X receptor and interaction with the bile acid response element II in the cholesterol 7-alpha hydroxylase promoter.
METHODS: We tested the effect of LPS on hepatic expression of cholesterol 7-alpha hydroxylase in C57BL/6 mice and Wistar rats. Further, we analyzed the binding activity of hepatic nuclear extracts to the bile acid response element II and the binding site for farnesoid X receptor heterodimers (ecdysone response element). RESULT: Lipopolysaccharide caused a 100-fold reduction of cholesterol 7-alpha hydroxylase mRNA levels in mice and a 10-fold reduction in rats. Protein levels of cholesterol 7-alpha hydroxylase also decreased in both species. These changes inversely correlated with the increased binding activity of nuclear proteins to the bile acid response element II and the ecdysone response element.
CONCLUSION: Lipopolysaccharide-induced repression of cholesterol 7-alpha hydroxylase occurs at the transcriptional level. The underlying mechanism involves an increased binding activity of nuclear proteins to the bile acid response element II and the ecdysone response element. In conclusion, the farnesoid and retinoid X receptors participate in LPS-induced cholesterol 7-alpha hydroxylase repression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492453     DOI: 10.1046/j.1365-2362.2003.01079.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  The acute phase response inhibits reverse cholesterol transport.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

2.  Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship.

Authors:  Jason M Ridlon; Joao Marcelo Alves; Phillip B Hylemon; Jasmohan S Bajaj
Journal:  Gut Microbes       Date:  2013-07-12

3.  Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection.

Authors:  Jun-Jun He; Jun Ma; Hany M Elsheikha; Hui-Qun Song; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2016-08-03       Impact factor: 3.876

4.  Serum bile acids in term and preterm neonates: A case-control study determining reference values and the influence of early-onset sepsis.

Authors:  Evelyn Zöhrer; Bernhard Resch; Hubert Scharnagl; Axel Schlagenhauf; Günter Fauler; Tatjana Stojakovic; Nora Hofer; Uwe Lang; Jörg Jahnel
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 5.  The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics.

Authors:  Jason M Ridlon; Jasmohan S Bajaj
Journal:  Acta Pharm Sin B       Date:  2015-02-09       Impact factor: 11.413

Review 6.  Gut-liver axis signaling in portal hypertension.

Authors:  Benedikt Simbrunner; Mattias Mandorfer; Michael Trauner; Thomas Reiberger
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.